Inventor
DAVID J. MALONEY
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds44%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
A61KPreparations for medical, dental or toiletry purposes19%
C07CAcyclic or carbocyclic compounds6%
PatentTitleYear
12,497,395Small molecule bromodomain inhibitors and uses therof202512,365,653Small molecule inhibitors of lactate dehydrogenase and methods of use thereof202511,897,845Small molecule inhibitors of lactate dehydrogenase and methods of use thereof202411,795,177Substituted quinoline analogs as aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors202311,505,559Substituted quinoline analogs as aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors202211,274,0774-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase202211,247,971Small molecule inhibitors of lactate dehydrogenase and methods of use thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to US HEALTH (6)· patent assignee history
2022–2025Patents assigned to UAB RES FOUND (3)· patent assignee history
2022–2025Patents assigned to UNIV PENNSYLVANIA (3)· patent assignee history
2022–2025Patents assigned to UNIV VANDERBILT (3)· patent assignee history
2022–2025Based in US· patent location history
2025Patents assigned to CONVERGENE LLC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| US HEALTH | 6 | 2022–2025 |
| UAB RES FOUND | 3 | 2022–2025 |
| UNIV PENNSYLVANIA | 3 | 2022–2025 |
| UNIV VANDERBILT | 3 | 2022–2025 |
| CONVERGENE LLC | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2022–2025 |